These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 7653961)

  • 21. p53 overexpression is frequent in European hepatocellular carcinoma and largely independent of the codon 249 hot spot mutation.
    Volkmann M; Hofmann WJ; Müller M; Räth U; Otto G; Zentgraf H; Galle PR
    Oncogene; 1994 Jan; 9(1):195-204. PubMed ID: 8302580
    [TBL] [Abstract][Full Text] [Related]  

  • 22. High prevalence of mutations at codon 249 of the p53 gene in hepatocellular carcinomas from Senegal.
    Coursaget P; Depril N; Chabaud M; Nandi R; Mayelo V; LeCann P; Yvonnet B
    Br J Cancer; 1993 Jun; 67(6):1395-7. PubMed ID: 8390289
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Alterations of tumor suppressor genes and allelic losses in human hepatocellular carcinomas in China.
    Fujimoto Y; Hampton LL; Wirth PJ; Wang NJ; Xie JP; Thorgeirsson SS
    Cancer Res; 1994 Jan; 54(1):281-5. PubMed ID: 7903205
    [TBL] [Abstract][Full Text] [Related]  

  • 24. APC, K-ras, and p53 gene mutations in colorectal cancer patients: correlation to clinicopathologic features and postoperative surveillance.
    Hsieh JS; Lin SR; Chang MY; Chen FM; Lu CY; Huang TJ; Huang YS; Huang CJ; Wang JY
    Am Surg; 2005 Apr; 71(4):336-43. PubMed ID: 15943410
    [TBL] [Abstract][Full Text] [Related]  

  • 25. State of the p53 gene in hepatocellular carcinomas of ground squirrels and woodchucks with past and ongoing infection with hepadnaviruses.
    Rivkina MB; Cullen JM; Robinson WS; Marion PL
    Cancer Res; 1994 Oct; 54(20):5430-7. PubMed ID: 7923176
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mutations of p53 gene in hepatocellular carcinoma: roles of hepatitis B virus and aflatoxin contamination in the diet.
    Hsia CC; Kleiner DE; Axiotis CA; Di Bisceglie A; Nomura AM; Stemmermann GN; Tabor E
    J Natl Cancer Inst; 1992 Nov; 84(21):1638-41. PubMed ID: 1279184
    [TBL] [Abstract][Full Text] [Related]  

  • 27. p53 mutations, chronic hepatitis B virus infection, and aflatoxin exposure in hepatocellular carcinoma in Taiwan.
    Lunn RM; Zhang YJ; Wang LY; Chen CJ; Lee PH; Lee CS; Tsai WY; Santella RM
    Cancer Res; 1997 Aug; 57(16):3471-7. PubMed ID: 9270015
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Reduction of p53 gene expression in human primary hepatocellular carcinoma is associated with promoter region methylation without coding region mutation.
    Pogribny IP; James SJ
    Cancer Lett; 2002 Feb; 176(2):169-74. PubMed ID: 11804744
    [TBL] [Abstract][Full Text] [Related]  

  • 29. p53 abnormalities in primary prostate cancer: single-strand conformation polymorphism analysis of complementary DNA in comparison with genomic DNA. The Cooperative Prostate Network.
    Gumerlock PH; Chi SG; Shi XB; Voeller HJ; Jacobson JW; Gelmann EP; deVere White RW
    J Natl Cancer Inst; 1997 Jan; 89(1):66-71. PubMed ID: 8978408
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mutations of p53 gene in gastric carcinoma in Taiwan.
    Wang JY; Lin SR; Hsieh JS; Hsu CH; Huang YS; Huang TJ
    Anticancer Res; 2001; 21(1B):513-20. PubMed ID: 11299797
    [TBL] [Abstract][Full Text] [Related]  

  • 31. P53 mutation and response to hepatic arterial floxuridine in patients with colorectal liver metastases.
    Khan ZA; Jonas SK; Feldmann KA; Patel H; Wharton RQ; Tarragona A; Ivison A; Allen-Mersh TG
    J Cancer Res Clin Oncol; 2001 Nov; 127(11):675-80. PubMed ID: 11710597
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The clinical significance of p53 gene mutation in hepatocellular carcinomas from Japan.
    Hayashi H; Sugio K; Matsumata T; Adachi E; Takenaka K; Sugimachi K
    Hepatology; 1995 Dec; 22(6):1702-7. PubMed ID: 7489977
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Mutations in the p53 and Ki-ras genes, microsatellite instability and site of tumor origin in colorectal cancer.
    Catalano T; Curia MC; Aceto G; Verginelli F; Cascinu S; Cama A; Mariani-Costantini R; Teti D; Battista P
    Oncol Rep; 2005 Sep; 14(3):625-31. PubMed ID: 16077965
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinical significance in molecular detection of p53 mutation in serum of patients with colorectal carcinoma.
    Ito T; Kaneko K; Makino R; Konishi K; Kurahashi T; Ito H; Katagiri A; Kushima M; Kusano M; Mitamura K; Imawari M
    Oncol Rep; 2003; 10(6):1937-42. PubMed ID: 14534722
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Analysis of the p53 gene in European hepatocellular carcinomas and hepatoblastomas.
    Debuire B; Paterlini P; Pontisso P; Basso G; May E
    Oncogene; 1993 Aug; 8(8):2303-6. PubMed ID: 8393166
    [TBL] [Abstract][Full Text] [Related]  

  • 36. P53 tumour-suppressor gene mutations are mainly localised on exon 7 in human primary and metastatic prostate cancer.
    Dahiya R; Deng G; Chen KM; Chui RM; Haughney PC; Narayan P
    Br J Cancer; 1996 Jul; 74(2):264-8. PubMed ID: 8688333
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Tumor heterogeneity in small hepatocellular carcinoma: analysis of tumor cell proliferation, expression and mutation of p53 AND beta-catenin.
    An FQ; Matsuda M; Fujii H; Tang RF; Amemiya H; Dai YM; Matsumoto Y
    Int J Cancer; 2001 Aug; 93(4):468-74. PubMed ID: 11477549
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Aberrations of the tumor suppressor p53 and retinoblastoma genes in human hepatocellular carcinomas.
    Murakami Y; Hayashi K; Hirohashi S; Sekiya T
    Cancer Res; 1991 Oct; 51(20):5520-5. PubMed ID: 1655254
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Genetic diversity at the p53 locus between primary human colorectal adenocarcinomas and their lymph-node metastases.
    Zhang JS; Caplin S; Bosman FT; Benhattar J
    Int J Cancer; 1997 Mar; 70(6):674-8. PubMed ID: 9096648
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Novel method for simultaneous analysis of p53 and K-ras mutations and p53 protein expression in single histologic sections.
    Yamashita K; Yoshida T; Shinoda H; Okayasu I
    Arch Pathol Lab Med; 2001 Mar; 125(3):347-52. PubMed ID: 11231481
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.